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Microorganisms that invade a vertebrate host are initially recognized by the innate immune
system through germline-encoded pattern-recognition receptors (PRRs). Several classes of
PRRs, including Toll-like receptors and cytoplasmic receptors, recognize distinct microbial
components and directly activate immune cells. Exposure of immune cells to the ligands of
these receptors activates intracellular signaling cascades that rapidly induce the expression
of a variety of overlapping and unique genes involved in the inflammatory and immune re-
sponses. New insights into innate immunity are changing the way we think about pathogen-
esis and the treatment of infectious diseases, allergy, and autoimmunity.Introduction
Vertebrates are constantly threatened by the invasion of
microorganisms and have evolved systems of immune
defense to eliminate infective pathogens in the body.
The mammalian immune system is comprised of two
branches: innate and acquired immunity. The innate im-
mune system is the first line of host defense against path-
ogens and is mediated by phagocytes including macro-
phages and dendritic cells (DCs). Acquired immunity is
involved in elimination of pathogens in the late phase of in-
fection as well as the generation of immunological mem-
ory. Acquired immunity is characterized by specificity
and develops by clonal selection from a vast repertoire
of lymphocytes bearing antigen-specific receptors that
are generated via a mechanism generally known as gene
rearrangement. The innate immune response is not com-
pletely nonspecific, as was originally thought, but rather
is able to discriminate between self and a variety of path-
ogens. The innate immune system recognizes microor-
ganisms via a limited number of germline-encoded pat-
tern-recognition receptors (PRRs). This is in contrast to
the large repertoire of rearranged receptors utilized by
the acquired system.
PRRs possess common characteristics. First, PRRs
recognize microbial components, known as pathogen-
associated molecular patterns (PAMPs), that are essential
for the survival of the microorganism and are therefore dif-
ficult for themicroorganism to alter. Second, PRRs are ex-
pressed constitutively in the host and detect the patho-
gens regardless of their life-cycle stage. Third, PRRs are
germline encoded, nonclonal, expressed on all cells of
a given type, and independent of immunologic memory.
Different PRRs react with specific PAMPs, show distinct
expression patterns, activate specific signaling pathways,
and lead to distinct antipathogen responses. The basic
machineries underlying innate immune recognition arehighly conserved among species, from plants and fruit
flies to mammals.
Here wewill review themechanisms of pathogen recog-
nition by the innate immune system, focusing on host
PRRs and their signaling pathways.
TLRs as Pattern-Recognition Receptors
TLRs are evolutionarily conserved from the worm Caeno-
rhabditis elegans to mammals (Akira and Takeda, 2004;
Beutler, 2004; Hoffmann, 2003; Janeway and Medzhitov,
2002). Toll, the founding member of the TLR family, was
initially identified as a gene product essential for the devel-
opment of embryonic dorsoventral polarity in Drosophila.
Later, it was also shown to play a critical role in the antifun-
gal response of flies (Lemaitre et al., 1996). To date, 12
members of the TLR family have been identified in mam-
mals. TLRs are type I integral membrane glycoproteins
characterized by the extracellular domains containing
varying numbers of leucine-rich-repeat (LRR) motifs and
a cytoplasmic signaling domain homologous to that of
the interleukin 1 receptor (IL-1R), termed the Toll/IL-1R
homology (TIR) domain (Bowie and O’Neill, 2000). The
LRR domains are composed of 19–25 tandem LRRmotifs,
each of which is 24–29 amino acids in length, containing
the motif XLXXLXLXX as well as other conserved amino
acid residues (XØXXØXXXXFXXLX; Ø = hydrophobic res-
idue). Each LRR consists of a b strand and an a helix con-
nected by loops. It was imagined that the LRR domain of
TLR would form a horseshoe structure with the ligand
binding to the concave surface. However, the three-
dimensional structure of the human TLR3 LRR motifs
has recently been elucidated, and its structure suggests
a somewhat different model in which negatively charged
dsRNA is more likely to bind the outside convex surface
of TLR3 (Choe et al., 2005). How general this mode ofCell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc. 783
Table 1. TLR Recognition of Microbial Components
Microbial Components Species TLR Usage
Bacteria
LPS Gram-negative bacteria TLR4
Diacyl lipopeptides Mycoplasma TLR6/TLR2
Triacyl lipopeptides Bacteria and mycobacteria TLR1/TLR2
LTA Group B Streptococcus TLR6/TLR2
PG Gram-positive bacteria TLR2
Porins Neisseria TLR2
Lipoarabinomannan Mycobacteria TLR2
Flagellin Flagellated bacteria TLR5
CpG-DNA Bacteria and mycobacteria TLR9
ND Uropathogenic bacteria TLR11
Fungus
Zymosan Saccharomyces cerevisiae TLR6/TLR2
Phospholipomannan Candida albicans TLR2
Mannan Candida albicans TLR4









ssRNA RNA viruses TLR7 and TLR8
Envelope proteins RSV, MMTV TLR4
Hemagglutinin protein Measles virus TLR2
ND HCMV, HSV1 TLR2
Host
Heat-shock protein 60, 70 TLR4
Fibrinogen TLR4
ND = not determined. See text for references.binding is will be answered with the crystallographic anal-
yses of other TLRs.
Based on their primary sequences, TLRs can be further
divided into several subfamilies, each of which recognizes
related PAMPs: the subfamily of TLR1, TLR2, and TLR6
recognizes lipids, whereas the highly related TLR7,
TLR8, and TLR9 recognize nucleic acids (Table 1). How-
ever, the TLRs are unusual in that some can recognize
several structurally unrelated ligands. For example, TLR4
recognizes a very divergent collection of ligands such as
lipopolysaccharide (LPS), the plant diterpene paclitaxel,
the fusion protein of respiratory syncytial virus (RSV), fi-784 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.bronectin, and heat-shock proteins, all of which have dif-
ferent structures.
TLRs are expressed on various immune cells, including
macrophages, dendritic cells (DCs), B cells, specific types
of T cells, and even on nonimmune cells such as fibro-
blasts and epithelial cells. Expression of TLRs is not static
but rather is modulated rapidly in response to pathogens,
a variety of cytokines, and environmental stresses. Fur-
thermore, TLRsmay be expressed extra- or intracellularly.
While certain TLRs (TLRs 1, 2, 4, 5, and 6) are expressed
on the cell surface, others (TLRs 3, 7, 8, and 9) are found
almost exclusively in intracellular compartments such as
Figure 1. Schematic Representation of Bacterial Cell Walls
Gram-positive bacteria have a thick layer of PG. Lipoteichoic acids and lipoproteins are embedded in this cell wall. The cell wall of Gram-negative
bacteria is characterized by the presence of LPS. Mycobacteria have a thick hydrophobic layer containing mycolyl arabinogalactan and dimycolate,
in addition to a lipid bilayer and a PG layer. Lipoarabinomannan (LAM) is a major cell-wall-associated glycolipid. Lipoproteins are common structures
for various types of bacteria.endosomes, and their ligands, mainly nucleic acids, re-
quire internalization to the endosome before signaling is
possible. The transmembrane and membrane-proximal
regions are important for the cellular compartmentaliza-
tion of these receptors.
TLRs activate the same signaling molecules that are
used for IL-1R signaling (Akira and Takeda, 2004). Stimu-
lation of cells with a TLR ligand recruits adaptor proteins
containing a TIR domain, such as myeloid differentiation
factor 88 (MyD88), to the cytoplasmic portion of the
TLRs through homophilic interaction of their TIR domains.
This results in the triggering of downstream signaling cas-
cades and production of proinflammatory cytokines and
chemokines. Cells prominently expressing TLRs include
antigen-presenting cells (APCs) such as DCs and macro-
phages, which ingest and degrade pathogens. The role of
TLR signaling in pathogen phagocytosis is controversial.
Early papers suggested a role of TLR in phagocyte matu-
ration, whereas a recent paper did not find such a role
(Blander and Medzhitov, 2004; Yates and Russell, 2005).
APCs also activate the adaptive immune response by mi-
grating from the infection site to the regional lymph node,
where they present microbe-derived antigens to naive
CD4+ T cells. At the same time, activated DCs express
costimulatory molecules essential to T cell activation
and can instruct the differentiation of naive CD4+ T cells
into T helper 1 (Th1) cells or Th2 cells. Th1 cells produce
interferon-g (IFN-g) and mediate the elimination of bacte-
rial and viral infection, while Th2 cells, which produce IL-4
and IL-13, are involved in the response against helminthinfection. Stimulation of most TLRs leads to Th1 rather
than Th2 differentiation. Thus, innate immunity is a key el-
ement in the inflammatory response aswell as the immune
response against pathogens.
Bacterial Recognition by TLRs
Gram-Negative and -Positive Bacterial Cell Wall
Bacteria can be classified into two major groups depend-
ing on the different staining characteristics of their cell
walls, namely Gram-positive and -negative bacteria (Fig-
ure 1). Some of the unique cell-wall components stimulate
immune cells and serve as PAMPs, recognized by individ-
ual TLRs. LPS, also known to be an endotoxin, is generally
the most potent immunostimulant among these cell-wall
components. A lipid portion of LPS termed ‘‘lipid A’’ is re-
sponsible for most of the pathogenic phenomena associ-
ated with Gram-negative bacterial infection such as endo-
toxin shock. LPS liberated from Gram-negative bacteria
associates with LPS binding protein (LBP), an acute-
phase protein present in the bloodstream, and then binds
to CD14, a glycosylphosphatidylinositol (GPI) linked pro-
tein expressed on the cell surface of phagocytes. LPS is
then transferred toMD-2, which associates with the extra-
cellular portion of TLR4, followed by oligomerization of
TLR4, a key molecule of LPS signaling (Poltorak et al.,
1998; Shimazu et al., 1999).
Different bacteria produce structurally different LPS
molecules varying in their phosphate patterns, numbers
of acyl chains, and fatty-acid composition. These varia-
tions are reflected in the varied biological activities of lipidCell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc. 785
A, as evidenced by the extremely reduced toxicity of
monophosphoryl lipid A. Furthermore, LPS preparations
from nonenteric bacteria, such as Legionella pneumophila
and Leptospira interrogans, are reported to act as TLR2,
but not TLR4, agonists, although such results should be
viewedwith caution due to the difficulty of removing impu-
rities from LPS preparations (Werts et al., 2001). In fact, it
has been shown that the TLR2-stimulating activity of an
LPS preparation from Porphyromonas gingivalis was due
to the presence of contaminating lipoproteins, not to LPS.
Consistent with their reduced response to Gram-nega-
tive bacteria, TLR4-mutated C3H/HeJ mice are highly
susceptible to infection by Salmonella typhimurium or
Neisseria meningitis. Interestingly, two cosegregating
missense mutations, Asp299Gly and Thr399Ile, have
been found in the human TLR4 gene (Cook et al., 2004).
The Asp299Gly polymorphism was found to be associ-
ated with impaired LPS signaling, increased susceptibility
to Gram-negative bacterial infections, and a lower risk of
atherosclerosis.
Components of Gram-positive bacterial cell walls can
also stimulate innate immunity. Although these bacteria
do not contain LPS, lipoteichoic acid (LTA) seems to func-
tion in a similar manner as an immune activator. Lipopro-
teins and peptidoglycan (PG), which are present in both
Gram-positive and Gram-negative bacteria, are also po-
tent immunostimulants. TLR2 plays a major role in detect-
ing Gram-positive bacteria and is involved in the recogni-
tion of a variety of microbial components, including LTA,
lipoproteins, and PG. TLR2 interacts physically and func-
tionally with TLR1 and TLR6, which appear to be involved
in the discrimination of subtle changes in the lipid portion
of lipoproteins. LTA, an amphiphilic, negatively charged
glycolipid, also contains a diacylated moiety and activates
the cells via the TLR2/TLR6 heterodimer (Alexopoulou
et al., 2002; Ozinsky et al., 2000; Takeuchi et al., 2001,
2002).
PG is composed of long linear sugar chains of alternat-
ing N-acetyl glucosamine (GlcNac) and N-acetyl muramic
acid (MurNac) that are interlinked by peptide bridges to
form a large macromolecular structure. TLR2 has been
reported to recognize PG, but this observation remains
controversial (Travassos et al., 2004). Studies using com-
ponents that have been biochemically purified frombacte-
ria are often inconclusive due to the possibility of contam-
inations, and chemically synthesized mimics of active
components should be used for definitive conclusions.
To date, only chemically pure lipopeptides have been un-
ambiguously demonstrated to be TLR2 stimulators.
The importance of TLR2 in the host defense against
Gram-positive bacteria has been demonstrated using
TLR2-deficient (TLR2/) mice, which were found to be
highly susceptible to challenge with Staphylococcus au-
reus or Streptococcus pneumoniae (Echchannaoui et al.,
2002; Takeuchi et al., 2000). A polymorphism in the human
TLR2 gene (Arg753Gln) has been shown to be associated
with a reduced response to different bacterial lipoproteins
and septic shock after infection by Gram-positive bacte-786 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.ria, especially staphylococcal septic shock (Cook et al.,
2004). This polymorphism was identified in a large group
of Caucasian subjects, and 6%–9% of the study popula-
tion was found to be heterozygous.
Uropathogenic bacteria are recognized by mouse
TLR11, although the specific components that are respon-
sible for this activation have not been identified (Zhang
et al., 2004). However, human TLR11 is nonfunctional be-
cause of the presence of a stop codon in the gene.
Flagellins and TLR5
Flagellin is the major protein constituent of bacteria
flagella, the motility apparatus used by many microbial
pathogens, and is a potent activator of innate immune
responses. A recent analysis of the crystal structure of a
Salmonella flagellin revealed that the flagellin domains
are composed of N- and C-terminal a helix chains (D0),
the central a helix chains (D1), and the hypervariable cen-
tral region with b sheets (D2 and D3) (Yonekura et al.,
2003). TLR5 is responsible for the detection of flagellin
and specifically recognizes the constant domain D1,
which is relatively conserved among different species
(Hayashi et al., 2001). TLR5 is expressed by epithelial
cells, monocytes, and immature DCs. Since TLR5 is baso-
laterally expressed on intestinal epithelia, flagellin is rec-
ognized by the host only when bacteria have invaded
across the epithelia. TLR5 is also highly expressed in the
lungs and seems to play an important role in the defense
against pathogens of the respiratory tract. Up to 10% of
individuals have a point mutation that introduces a stop
codon within the ligand binding domain of TLR5
(TLR5392STOP). The TLR5392STOP mutant protein functions
as a dominant-negative receptor that severely impairs
TLR5-mediated signaling and is associated with suscepti-
bility to pneumonia caused by the flagellated bacterium
L. pneumophila (Hawn et al., 2003). Some bacteria, such
as Helicobacter pylori and Campylobacter jejuni, produce
flagellins that lack proinflammatory properties and there-
fore escape the flagellin-specific host immune responses
(Andersen-Nissen et al., 2005).
Bacterial DNA
Bacterial genomic DNA is also an immunostimulant and is
recognized by TLR9 (Hemmi et al., 2000; Krieg, 2002). Its
stimulatory effect is due to the presence of unmethylated
CpG dinucleotides in a particular base context designated
CpG-DNA.Although theCpGmotif is abundant in bacterial
genomes, its frequency is suppressed and it is highly
methylated in mammalian genomes. The methylated
CpG motif does not activate mammalian immune cells.
CpG-DNA manifests strong immunostimulatory activities,
including the induction of inflammatory cytokine produc-
tion and Th1 immune responses. The particular DNA se-
quences that provoke an immune response vary between
species. Synthetic oligonucleotides containing the CpG
motif are equivalent tobacterial DNA in their immunostimu-
latory activity. Since TLR9 resides in the endosome, bacte-
rial DNA must be delivered to this intracellular compart-
ment, where the acidic and reducing conditions lead to
the degradation of double-stranded DNA into multiple
single-strandedCpG-motif-containing regions that subse-
quently interact directly with TLR9 (Ahmad-Nejad et al.,
2002; Latz et al., 2004). Compounds that block endosomal
acidification, such as bafilomycin and chloroquine, inhibit
CpG-DNA-driven signaling (Hacker et al., 1998). An in vitro
experiment also demonstrated that TLR9 interacted with
CpG-DNA more strongly at the acidic pH (6.5 or 5.5) con-
dition (Rutz et al., 2004). However, the requirement of
acidic pH inCpG recognition has recently been challenged
by a study showing that a chimeric TLR9 localized to the
cell surface is still capable of responding to CpG-DNA
(Barton et al., 2006). The study suggests that the expres-
sion of TLR9 in intracellular compartments is important
for preventing recognition of self-DNA. Therefore, further
studies are required for clarifying the role of endosomal
acidification in CpG DNA recognition.
PAMPs in Mycobacteria
Mycobacteria are intracellular bacteria that survive in the
hostmacrophages by a number of elaboratemechanisms.
The mycobacterial cell wall is composed of a thick waxy
mixture of lipids and polysaccharides and is characterized
by a high content of mycolic acid (Figure 1). Purifiedmyco-
bacterial cell-wall components have been shown to pref-
erentially activate TLR2 and, to a lesser extent, TLR4. Lipo-
mannan (LM) and lipoarabinomannan (LAM) are related
powerful immunomodulatory lipoglycans. LM is further
arabinosylated to give LAM. The arabinan domain is cap-
ped by either mannosyl (ManLAM) or a phosphoinositide
residue (PILAM). PILAM is a potent TLR2 stimulator that
has been identified in nonpathogenic, fast-growing spe-
cies such as Mycobacterium smegmatis (Gilleron et al.,
2003). In contrast, ManLAM is a powerful anti-inflamma-
tory molecule that is found in slow-growing virulent myco-
bacteria, such asMycobacterium tuberculosis,Mycobac-
terium bovis BCG, andMycobacterium avium. Since LMs
from both pathogenic and nonpathogenic mycobacterial
species, independent of their origin, induce inflammatory
cytokines in a TLR2-dependent manner, the ultimate re-
sponse against virulent mycobacteria may be determined
by the ManLAM/LM ratio in the cell wall (Quesniaux et al.,
2004).
In addition, TLR2 in association with TLR1 can recog-
nize a 19 kDa cell-wall-associated lipoprotein, a secreted
antigen ofM. tuberculosis that is also a potent cytokine in-
ducer of macrophages (Thoma-Uszynski et al., 2001), and
TLR9 can be activated by mycobacterial DNA, which may
be released during endolysosomal degradation.
The role of individual TLRs in mycobacterial infections
has been examined using TLR-deficient mice. In the case
of the nonpathogenic species M. smegmatis, TLR2 is in-
dispensable for effective clearance ofM. smegmatis from
the pulmonary compartment. In contrast, in the case of
infections with virulent mycobacteria, such as M. avium
and M. tuberculosis, mice deficient in TLR2, TLR4, or
TLR6 appear to show minor or no defects in the control
of infection, although conflicting results have been
reported to date.Mycobacterium leprae is the causative bacteriumof lep-
rosy, whose clinical manifestations depend on the host
cell-mediated immune responseagainst thepathogen. Tu-
berculoid leprosypatientsmanifest a strongTh1 response,
resulting in a few localized and often self-healing pauciba-
cillary lesions. In contrast, lepromatous leprosy patients
manifest a predominant Th2 response, leading to a dis-
seminated disease involving extended multibacillary le-
sions of the skin and nerves. The TLR2/TLR1 heterodimers
are responsible for the cellular activation mediated by M.
leprae as well as its triacylated 19 kDa and 33 kDa lipopro-
tein (Krutzik et al., 2003). TLR2 and TLR1 are strongly ex-
pressed on monocytes and DCs in lesions from tubercu-
loid leprosy patients but not in those from lepromatous
leprosy patients. It is reported that a mutation in the intra-
cellular domain of hTLR2 (Arg677Trp) is associatedwith le-
promatous leprosy in a Korean population (Malhotra et al.,
2005). These findings demonstrate that TLR2 plays a criti-
cal role in the innate immune response toM. leprae.
Fungal Recognition by TLRs
The observation that Toll-deficient Drosophila are highly
susceptible to fungal infection led to the assumption that
mammalian TLRs also participate in antifungal immunity.
Several fungal PAMPs located in the cell wall or on the
cell surface of fungi are recognized by TLR2 or TLR4.
The Th1 response is critical in protection against fungi.
Although TLR-mediated signals mostly induce Th1-
directed responses, activation of TLR2 is less inflamma-
tory and favors the development of the Th2 response
through the induction of IL-10 (Agrawal et al., 2003). In-
deed, in vivo infection experiments using mutant mice
suggest differential roles of TLR2 and TLR4 in fungal infec-
tion. TLR4/ mice showed increased susceptibility to
disseminated Candida infection, whereas TLR2/ mice
showed increased resistance (Netea et al., 2004). Infected
TLR2/ mice showed normal production of inflammatory
cytokines such as TNF and IL-1 but severe impairment
in IL-10 production, indicating that C. albicans induces
immunosuppression through IL-10. A similar escape
mechanism from the host defense is also observed in
A. fumigatus infection. A. fumigatus grows in two forms,
conidia and hyphae. TLR2 and TLR4 both recognize co-
nidia, whereas the hyphae are only recognized by TLR2;
thus, the phenotypic switch to hyphae from conidia results
in the release of IL-10, which impairs the cellular immune
response necessary for the Aspergillus clearance.
Dectin-1 is a type II transmembrane protein with a C
type lectin domain in the extracellular region and an
ITAM motif in the intracellular domain. Dectin-1 binds
b-glucan and is the primary receptor on macrophages
for phagocytosis of various fungi (Brown et al., 2002). It
has been demonstrated that dectin-1 can collaborate
with TLR2 in response to yeast to elicit a strong inflam-
matory response via recruitment of the protein tyrosine
kinase Syk (Gantner et al., 2003; Rogers et al., 2005;
Underhill et al., 2005). However, although b-glucan is pre-
sented during C. albicans yeast growth, it is not presentedCell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc. 787
during filamentous growth. As a consequence, dectin-1-
mediated antimicrobial defenses are not effective against
filaments, which may explain why filaments are more viru-
lent. In addition to dectin-1, other receptors such as the
type 3 complement receptor, the mannose receptor, and
DC-SIGN are implicated in the recognition and phagocy-
tosis of Candida (Takahara et al., 2004).
Protozoan-Parasite Recognition by TLRs
Components of protozoan parasites are also sensed by
TLRs. These protozoan parasites include Trypanosoma
cruzi, Trypanosoma brucei, Toxoplasma gondii, Leish-
mania major, and Plasmodium falciparum. Trypanosoma-
derived molecules, such glycosylphosphatidylinositol-
mucin (tGPI-mucin), glycoinositolphospholipids (GIPLs),
and genomic DNA, have been reported to activate TLR2,
TLR4, and TLR9, respectively (Gazzinelli et al., 2004). A
soluble extract of T. gondii tachyzoites (STAg) contains
a potent, heat-labile inducer of IL-12. The active compo-
nent was recently identified as a profilin-like molecule
that is recognized by murine TLR11 (Yarovinsky et al.,
2005). Profilins are small ubiquitous proteins that were
originally described as actin binding proteins. Although
their exact cellular functions have not yet been estab-
lished, their predicted actin binding activities suggest their
involvement in parasite motility and/or invasion. However,
human TLR11 is nonfunctional due to the presence of
a stop codon in the gene.
Blood-stage schizonts or soluble schizont extracts from
Plasmodium activate plasmacytoid DCs (pDCs) in a TLR9-
dependent manner (Pichyangkul et al., 2004). The soluble
schizont extracts are heat labile and can be precipitated
with ammonium sulfate, unlike DNA. Recently, hemozoin,
a heme byproduct, was shown to be a TLR9 stimulant
(Coban et al., 2005). However, hemozoin is not heat labile
and does not induce type I IFN production by pDCs, in
contrast to the heat-labile schizont extracts, implying the
existence of an additional TLR9 stimulator, probably a pro-
tein in the soluble schizont extracts.
The Th1/Th2 balance is well established to be of critical
importance to the fate of parasites. Th1 responses are
associated with the elimination of protozoan parasites,
whereas Th2 responses are associated with uncontrolled
parasite growth. Although mice deficient for individual
TLRs do not show impaired responses to live protozoan
parasites, mice deficient for MyD88, which causes a
more general defect in TLR responses, showed impaired
production of proinflammatory cytokines as well as en-
hanced parasitemia and mortality in response to protozoa
infection (Adachi et al., 2001). This indicates that proto-
zoan parasites may be recognized by more than one TLR.
Viral Recognition by TLRs
Viruses contain genetic material composed of either DNA
or RNA (but not both) that encodes viral structural compo-
nents and synthetic and replication enzymes. Various
structural components, including viral DNA, double-
stranded RNA (dsRNA), single-stranded RNA (ssRNA),788 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.and surface glycoproteins, are recognized as PAMPs by
TLRs and other PRRs. Among the TLR family members,
TLR3, TLR7, TLR8, and TLR9 are involved in the recogni-
tion of viral nucleotides. The recognition of viral compo-
nents by PRRs commonly induces type I IFN production
that can activate target cells in both autocrine and para-
crine manners.
Viral DNA Is Recognized by TLR9
DNA viruses, including herpes simplex virus 1 (HSV-1),
HSV-2, and murine cytomegalovirus (MCMV), contain ge-
nomes that are rich in CpG-DNA motifs, and they activate
inflammatory cytokines and type I IFN secretion by stimu-
lation of TLR9 (Hochrein et al., 2004; Krug et al., 2004a,
2004b; Lund et al., 2003; Tabeta et al., 2004). The TLR9-
mediated IFN-a response to HSV-1 and HSV-2 is cell-
type specific and limited to pDCs, a DC subpopulation
characterized by their ability to secrete high levels of IFN
in response to viral infection. A group of synthetic oligonu-
cleotides, termed A/D type CpG-DNAs, are also potent
type I IFN inducers in pDCs (Krug et al., 2001; Verthelyi
et al., 2001). They are characterized by the presence of
a phosphorothioate-modified poly G stretch at the 50
and 30 ends and a phosphodiester CpGmotif in the central
portion. In contrast, conventional phosphorothioate-mod-
ified CpG-DNAs, termed B/K type CpG-DNAs, do not
stimulate pDCs to produce type I IFNs, although they
can stimulate cells to produce proinflammatory cytokines.
Recognition of HSV-2 by pDCs does not require virus rep-
lication. Indeed, both live and UV-inactivated HSV-2 in-
duces identical IFN-a secretion from pDCs. In contrast,
in the case of macrophages that produce 5- to 10-fold
less IFN-a in response to viral infections, HSV-2-induced
expression of TNF and RANTES is mainly dependent on
TLR9, whereas type I IFN is induced in a TLR9-indepen-
dent manner (Hochrein et al., 2004). This is also supported
by a study showing that mice lacking TLR9 or MyD88 can
still control HSV-1 infection initiated either by footpad or
eye inoculation, suggesting that cells other than pDCs
may have a TLR9- and MyD88-independent system that
exerts effective anti-viral responses(Krug et al., 2004b).
Single-Stranded RNA Is Recognized
by TLR7 and TLR8
The TLR7 and TLR8 genes show high homology to each
other, and are both located on the X chromosome. Mouse
TLR7 and human TLR8 recognize synthetic antiviral imida-
zoquinoline components (R848, Imiquimod, etc.) and
some guanine nucleotide analogs (loxoribine etc.) as well
as uridine-rich or uridine/guanosine-rich ssRNA of both
viral and host origins (Hemmi et al., 2002; Heil et al.,
2004; Diebold et al., 2004). Human TLR8 also recognize
R848. Although both TLR7 and TLR8 are expressed in
mice, mouse TLR8 appears to be nonfunctional. TLR7
and TLR8 are expressedwithin the endosomalmembrane,
indicating that the accessibility of ssRNA may be a key
factor for cell activation via these receptors. Many envel-
oped viruses traffic into the cytosol through the endoso-
mal compartment. Thephagolysosome is ahighly acidified
environment containing abundant degradation enzymes
that may damage the viral particles, leading to ssRNA re-
lease and recognition by TLR7 or TLR8. Furthermore,
when virus-infected apoptotic cells are taken upbyphago-
cytes, viral RNAs may be released from these cells in the
phagolysosome. Unlike virus particles whose genomes
are sheltered in the capsid, self RNAs are subject to deg-
radation by extracellular RNases when they are released
from the cell, and rarely reach the endocytic compartment.
Double-Stranded RNA Is Recognized by TLR3
dsRNA, along with its synthetic analog, polyinosine-
deoxycytidylic acid (poly I:C), is a potent inducer of type
I IFNs and is recognized by TLR3 (Alexopoulou et al.,
2001). dsRNA can be generated during viral infection
as a replication intermediate for ssRNA viruses or as a
by-product of symmetrical transcription in DNA viruses.
TLR3 is specifically expressed in conventional DCs
(cDCs) that avidly phagocytose dying cells, but not in
pDCs. TLR3 is also expressed in a variety of epithelial
cells, including airway, uterine, corneal, vaginal, cervical,
biliary, and intestinal epithelial cells, which function as ef-
ficient barriers to infection. Expression of TLR3 is rapidly
and dramatically upregulated by treatment with poly I:C
or IFN-a/b. Interestingly, although uterine epithelial cells
or corneal epithelial cells express a wide range of TLRs,
only poly I:C stimulates these cells. Unlike DCs, these ep-
ithelial cells appear to express TLR3 on their cell surface.
Furthermore, TLR3 is strongly expressed in the brain, spe-
cifically in astrocytes and glioblastoma cell lines, indicat-
ing a specific role in the brain and/or in the response to en-
cephalitogenic viruses. Since dsRNA is a universal viral
PAMP, it has been assumed that TLR3 would have a key
role in antiviral immunity. However, several lines of evi-
dence have demonstrated that TLR3 is not required for
the initial, cell-autonomous recognition of viral infection
that induces the first wave of type I IFN production (Lopez
et al., 2004). Consistent with this finding, TLR3/mice fail
to show increased susceptibility to many viral infections
such as MCMV, VSV, lymphocytic choriomeningitis virus
(LCMV), and reovirus (Edelmann et al., 2004). The West
Nile virus appears to benefit from its interaction with
TLR3, indicating a peripheral inflammatory response via
TLR3,which causes a disruption of the blood-brain barrier,
and enables virus entry into the brain (Wang et al., 2004).
Consistent with this observation, TLR3/ mice are more
resistant to lethal West Nile virus infection. Thus, the role
of TLR3 in the antiviral response is still largely unclear.
TLR3 has been reported to promote crosspresentation of
virus-infected cells through engagement of virus-derived
RNAs (Schulz et al., 2005). Immunization with virus-in-
fected cells or cells containing synthetic dsRNA leads to
a striking increase in CTL crosspriming against cell-asso-
ciated antigens, which is largely dependent on TLR3 ex-
pression by antigen-presenting cells.
Viral Glycoproteins Are Recognized
by TLR2 and TLR4
Some viral-envelope proteins can be recognized by TLR4
or TLR2. Detection mostly results in the production of
proinflammatory cytokines, but not type I IFNs, implyingthat the response leads to the inflammation rather than
specific antiviral responses. For instance, the fusion (F)
protein from RSV has been identified as a viral component
that activates TLR4 (Kurt-Jones et al., 2000). The impor-
tance of TLR4 activation during RSV infection in vivo
was demonstrated with TLR4/ mice, which exhibited
lower levels of infiltrating mononuclear cells and reduced
production of IL-12 compared to their wild-type counter-
parts, resulting in a reduced rate of viral clearance. The en-
velope protein (Env) of mouse mammary tumor virus
(MMTV) also activates TLR4. Env directly activates B cells
via TLR4 to allow an initial round of infection, and MMTV
enhances the expression of its entry receptor, CD71, on
DCs to facilitate virus entry (Burzyn et al., 2004). Thus,
the MMTV-TLR interaction may favor the virus and repre-
sent a strategy to subvert the antiviral response. TLR2 is
also activated by viruses or viral components such as
measles virus (MV) hemagglutinin protein, human CMV,
and HSV-1 (Bieback et al., 2002; Compton et al., 2003).
It has been suggested that TLR2-mediated cytokine re-
sponses to HSV-1 are responsible for a significant portion
of the morbidity and mortality associated with HSV-1 in-
fection (Kurt-Jones et al., 2004).
Thus, various viral components are detected by TLRs,
and this leads to the vigorous production of type I IFNs
as well as proinflammatory cytokines. Nevertheless, anti-
viral host defense appears to involve more than just the
TLR system. In RNA Helicases and Double-Stranded
RNA, we will discuss TLR-independent viral detection
mechanisms and their relationships to TLRs.
The TLR Signaling Pathway in General
The engagement of TLRs by microbial components trig-
gers the activation of signaling cascades, leading to the in-
duction of genes involved in antimicrobial host defense
(Figure 2). After ligand binding, TLRs dimerize and un-
dergo conformational changes required for the recruit-
ment of TIR-domain-containing adaptor molecules to the
TIR domain of the TLR. There are four adaptor molecules,
namely MyD88, TIR-associated protein (TIRAP)/MyD88-
adaptor-like (MAL), TIR-domain-containing adaptor pro-
tein-inducing IFN-b (TRIF)/TIR-domain-containing mole-
cule 1 (TICAM1) (Oshiumi et al., 2003; Yamamoto et al.,
2002b), and TRIF-related adaptor molecule (TRAM). The
differential responses mediated by distinct TLR ligands
can be explained in part by the selective usage of these
adaptor molecules. MyD88 and TRIF are responsible for
the activation of distinct signaling pathways, leading to
the production of proinflammatory cytokines and type I
IFNs, respectively.
Proinflammatory Cytokine Production via TLRs
MyD88 is critical for the signaling from all TLRs except
TLR3. Upon stimulation, MyD88 associates with the cyto-
plasmic portion of TLRs and then recruits IL-1R-associ-
ated kinase 4 (IRAK-4) and IRAK-1 through a homophilic
interaction of the death domains (Figure 2). In TLR2 and
TLR4 signaling, another adaptor, TIRAP/Mal, is required
for recruiting MyD88 to the receptor (Fitzgerald et al.,Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc. 789
Figure 2. The TLR Signaling Pathway
TLRs and IL-1R share common signaling path-
ways in general. Stimulation with their ligands
recruits TIR-domain-containing adaptors in-
cluding MyD88 and TIRAP to the receptor,
and the subsequent formation of a complex
of IRAKs, TRAF6, and IRF-5 is induced.
TRAF6 acts as an E3 ubiquitin ligase and cata-
lyzes the K63-linked polyubiquitin chain on
TRAF6 itself and NEMOwith E2 ubiquitin ligase
complex of UBC13 and UEV1A. This ubiquiti-
nation activates the TAK1 complex, resulting
in the phosphorylation of NEMO and activation
of the IKK complex. Phosphorylated IkB un-
dergoes K48-linked ubiquitination and degra-
dation by the proteasome. Freed NF-kB trans-
locates into the nucleus and initiates the
expression of proinflammatory cytokine genes.
Simultaneously, TAK1 activates the MAP ki-
nase cascades, leading to the activation of
AP-1, which is also critical for the induction of
cytokine genes. TLR4 triggers the MyD88-in-
dependent, TRIF-dependent signaling path-
way via TRAM to induce type I IFNs. TRIF acti-
vates NF-kB and IRF-3, resulting in the
induction of proinflammatory cytokine genes
and type I IFNs. TRAF6 and RIP1 induce
NF-kB activation and TBK1/IKK-i phosphory-
late IRF-3, which induces the translocation of
IRF-3.2001; Horng et al., 2001, 2002; Yamamoto et al., 2002a).
The essential role of IRAK-4 in IL-1R/TLR responses is
demonstrated by the defective responses observed in
IRAK-4/ mice and by the poor defenses against bacte-
rial infection observed in patients having autosomal reces-
sive amorphic mutations in IRAK-4 (Picard et al., 2003;
Suzuki et al., 2003). After IRAK-1 associates with MyD88,
it is phosphorylated by the activated IRAK-4 and subse-
quently associates with TNFR-associated factor 6
(TRAF6), which acts as an ubiquitin protein ligase (E3) (Li
et al., 2002). Subsequently, TRAF6, together with a ubiqui-
tination E2 enzyme complex consisting of UBC13 and
UEV1A, catalyzes the formation of a K63-linked polyubi-
quitin chain on TRAF6 itself and on IKK-g/NF-kB essential
modulator (NEMO) (Deng et al., 2000). A complex com-
posed of TGF-b-activated kinase 1 (TAK1) and the TAK1
binding proteins, TAB1, TAB2, and TAB3, is also recruited
to TRAF6 (Wang et al., 2001). TAK1 then phosphorylates
IKK-b and MAP kinase kinase 6 (MKK6), which modulates790 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.the activation of NF-kB and MAP kinases, resulting in in-
duction of genes involved in inflammatory responses.
In addition to NF-kB, the transcription factor IRF-5 reg-
ulates the expression of cytokine genes (Takaoka et al.,
2005). Upon stimulation with TLR ligands, IRF-5 translo-
cates into the nucleus and binds potential IFN-stimulated
response element (ISRE) motifs present in the promoter
regions of cytokine genes. IkBz, an IkB-like molecule, is
also indispensable for induction of a subset of genes acti-
vated in TLR signaling (Yamamoto et al., 2004). It is rapidly
induced by stimulation with TLR ligands, but not TNF, and
activates the IL-6, IL-12, and other inflammatory genes by
associating with NF-kB p50.
Type I IFN Production via TLRs
TRIF-Dependent Pathway. Stimulation with TLR3, TLR4,
TLR7, and TLR9 ligands, but not the TLR2 ligand, induces
type I IFN production in addition to proinflammatory sig-
nals. TLR3 and TLR4 have the ability to induce IFN-b
and IFN-inducible genes in MyD88/ cells. The activity
of these pathways leads to DC maturation, expression of
costimulatory molecules, and IFN-a/b secretion (Kaisho
et al., 2001). This MyD88-independent pathway is initiated
by another TIR-domain-containing adaptor, TRIF (Hoebe
et al., 2003; Yamamoto et al., 2003a). TRAM, another
TIR-domain-containing adaptor, is specifically involved
in TLR4 signaling (Fitzgerald et al., 2003b; Yamamoto
et al., 2003b). TRAM associates with TLR4 and TRIF, sug-
gesting that TRAM acts as a bridging adaptor between
TLR4 and TRIF.
TRIF interacts with receptor-interacting protein 1 (RIP1),
which is responsible for the activation of NF-kB (Meylan
et al., 2004). On the other hand, TRIF activates TRAF-
family-member-associated NF-kB activator (TANK)
binding kinase 1 (TBK1; also known as NAK or T2K) via
TRAF3 (Hacker et al., 2006; Oganesyan et al., 2006).
TBK1 comprises a family with inducible IkB kinase
(IKK-i, also known as IKK-3) and these kinases directly
phosphorylate IRF-3 and IRF-7 (Fitzgerald et al., 2003a;
Sharma et al., 2003). Analysis of cells lacking TBK1 and
IKK-i revealed that TBK1 and, to a lesser extent, IKK-i
are responsible for TRIF-mediated IFN responses (Hemmi
et al., 2004; McWhirter et al., 2004; Perry et al., 2004).
Phosphorylated IRF-3 and IRF-7 form homodimers, trans-
locate into the nucleus, and bind to the ISREs, resulting in
the expression of a set of IFN-inducible genes. Among
nine IRF family members, IRF-3 and IRF-7 are essential
for the induction of type I IFN production since virus-me-
diated IFN production is severely impaired in IRF-7/
mice and was abrogated in IRF-3/IRF-7/ cells (Honda
et al., 2005b). Interestingly, TLR4-induced type I IFN pro-
duction is impaired in IRF-3/ mice, suggesting the dis-
tinct role of IRF-3 and IRF-7 in TLR- and virus-mediated
signaling (Sakaguchi et al., 2003).
TLR7- and TLR9-Mediated Type I IFN Production in
pDCs. TLR7 and TLR9 are highly expressed in pDCs, and
stimulation of pDCs, but not cDCs,with TLR7and9 ligands
leads to induction of IFN-a. Intriguingly, TLR9-mediated
IFN-a secretion occurs in a MyD88-dependent manner,
in contrast to TLR3- or TLR4-mediated IFN responses,
which are dependent on TRIF but not on MyD88. In addi-
tion, TLR9-mediated IFN production does not depend on
TBK1, suggesting that the signaling pathways activated
by TLR9 are different from those activated by TRIF.
In pDCs, IRF-7 plays a critical role in the expression of
type I IFNs. Upon stimulation, a complex comprised of
MyD88, IRAK-4, IRAK-1, TRAF6, and IRF-7 is formed
and recruited to the TLR (Figure 3) (Honda et al., 2004; Ka-
wai et al., 2004). pDCs lacking MyD88 or IRAK-4 failed to
produce either inflammatory cytokines or IFN-a in re-
sponse to CpG-DNA stimulation. On the other hand,
IRAK-1, which can potentially serve as an IRF-7 kinase,
appears to mediate TLR7- and TLR9-induced IFN-a pro-
duction in pDCs since this response is absent in IRAK-
1/ pDCs yet inflammatory cytokines are produced nor-
mally (Uematsu et al., 2005). Furthermore, IRF-7 activation
by the TLR9 ligand is impaired in IRAK-1/ pDCs in spite
of normal NF-kB activation, suggesting that IRAK-1 spe-Ccifically mediates IFN-a induction downstream of MyD88
and IRAK-4.
A/D type CpG-DNAs are potent inducers of IFN-a in
pDCs but not in cDCs, but the molecular mechanism un-
derlying this difference is not understood. One explanation
is that pDCs express high amounts of IRF-7, a key tran-
scription factor for IFN-a synthesis, while cDCs express
lower levels. A recent paper has proposed an additional
explanation: that A/D type CpG-DNAs are retained longer
in endosomal vesicles in pDCs but are rapidly transferred
to the lysosome in cDCs, thus facilitating encounters be-
tween the DNA and TLR9-MyD88-IRF-7 complexes in
pDCs (Honda et al., 2005a).
Cytoplasmic Pathogen Recognition System
TLRs recognize pathogens at either the cell surface or ly-
sosome/endosome membranes, suggesting that the TLR
system is not used for the detection of pathogens that
have invaded the cytosol. These pathogens are detected
by various cytoplasmic PRRs, which activate a number
of signaling pathways. A large family of cytoplasmic
PRRs has been cloned to date. Currently, they are roughly
subclassified into the NOD-LRR proteins and the CARD-
helicase proteins. These protein families are implicated
in the recognition of bacterial and viral components, re-
spectively.
NOD-LRR Proteins and Their Functions
NOD-LRR proteins are implicated in the recognition of
bacterial components. Proteins in this family possess
LRRs that mediate ligand sensing; a nucleotide binding
oligomerization domain (NOD); and a domain for the initi-
ation of signaling, such as CARDs, PYRIN, or baculovirus
inhibitor of apoptosis repeat (BIR) domains (Inohara et al.,
2005; Martinon and Tschopp, 2005).
Among the large number of NOD-LRR family members,
the functions of several proteins have been studied. These
proteins include NOD1 and NOD2, which both contain
N-terminal CARD domains. NOD1 and NOD2 detect
g-D-glutamyl-meso-diaminopimelic acid (iE-DAP) and
muramyl dipeptide (MDP), found in bacterial PG, respec-
tively (Figure 4) (Chamaillard et al., 2003; Girardin et al.,
2003). Consistently, macrophages lacking either NOD1
or NOD2 fail to produce cytokines in response to the cor-
responding ligands (Kobayashi et al., 2005). A missense
point mutation in the human NOD2 gene is correlated
with susceptibility to Crohn’s disease, an inflammatory
bowel disease. Ligand binding to NOD1 and NOD2
causes their oligomerization and results in NF-kB acti-
vation through the recruitment of RIP2/RICK, a serine/
threonine kinase, to the NODs via their respective CARD
domains by homophilic interactions.
Infection with bacteria induces activation of caspase-1,
which catalyzes the processing of pro-IL-1b to produce
the mature cytokines. A complex of proteins responsible
for these catalytic processes has been purified and desig-
nated the inflammasome (Figure 4) (Martinon et al., 2002).
The inflammasome consists of caspase-1; caspase-5;
ASC; and members of the NALP family, which are PYRIN-ell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc. 791
Figure 3. Mechanisms of Viral Detection
In cDCs, TLR3-dependent and RIG-I-dependent pathways operate to detect viral infection. Recognition of dsRNA by TLR3 in the endosomal
membrane recruits TRIF to the receptor, which induces proinflammatory cytokines and type I IFNs via the RIP1/TRAF6-NF-kB pathway and the
TBK1/IKK-i-IRF-3/IRF-7 pathway, respectively. In contrast, detection of dsRNA in the cytoplasm by RIG-I activates TBK1/IKK-i through IPS-1, which
is localized on the mitochondrial membrane.
In pDCs, TLR7 and TLR9 recognize viral ssRNA and DNA, respectively. Stimulation with TLRs recruits a complex of MyD88, IRAK-4, IRAK-1, TRAF6,
and IRF-7. Phosphorylated IRF-7 translocates into the nucleus and upregulates the expression of type I IFN genes.domain-containing proteins that also contain NOD-LRR.
ASC (apoptosis-associated speck-like protein containing
a CARD) is an adaptor protein that contains a PYRIN do-
main and a CARD. NALPs recruit ASC through a homo-
typic interaction between the PYRIN domains, and ASC
in turn recruits caspase-1 via its CARD, leading to the ac-
tivation of IL-1b and IL-18 processing. ASC/ macro-
phages exhibit defective maturation of IL-1b and IL-18
(Mariathasan et al., 2004). The ligands for NALP family
members are currently unknown, except for NALP3, which
is involved in the recognition of bacterial RNA, ATP, and
uric-acid crystals (Kanneganti et al., 2006; Mariathasan
et al., 2006; Martinon et al., 2006). Ipaf, another CARD-
containing NOD-LRR protein, is responsible for S. typhi-
murium-induced, but not TLR-induced, caspase-1 activa-
tion (Mariathasan et al., 2004).
NAIP5, a NOD-LRR protein containing BIR domains, is
associated with host susceptibility to the intracellular792 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.pathogen L. pneumophila (Diez et al., 2003). Although
NAIP5 is assumed to function as a cytoplasmic sensor
of Legionella, the specific ligands of NAIP5 and its signal-
ing pathway remain to be identified.
RNA Helicases and Double-Stranded RNA
dsRNA that is synthesized in the cytoplasm of the cell or
that is present in viral genomes already released into the
cell is not accessible to TLR3, the TLR that recognizes
dsRNAs. Indeed, most virus-infected cells produce type
I IFNs in a TLR3-independent manner. Moreover, fibro-
blasts and cDCs lacking MyD88 and TRIF are still capable
of inducing type I IFNs after viral infection, indicating that
the TLR system is not required for viral detection in at least
several cell types (Kato et al., 2005).
Retinoic-acid-inducible protein I (RIG-I) is an IFN-
inducible protein containing CARDs and a DExD/H box
helicase domain and has been identified as a cytoplasmic
dsRNA detector (Figure 3) (Yoneyama et al., 2004).
Figure 4. Cytoplasmic Bacterial Detectors and Their Signaling
NOD-LRR proteins recognize bacterial proteins in the cytoplasm and trigger signaling pathways. NOD1 and NOD2 recognize iE-DAP and MDP,
respectively, and activate NF-kB via RIP2/RICK. MDP is also recognized by NALP3, which forms an inflammosome comprised of ASC, CARDINAL,
and caspase-1. Activated caspase-1 cleaves pro-IL-1b for the maturation of IL-1b. Another NOD-LRR protein, IPAF, is activated by Salmonella and
induces maturation of IL-1b by associating with caspase-1.Overexpression of RIG-I has been shown to enhance
Newcastle disease virus (NDV)- and dsRNA-mediated
IFN responses on the cells. Melanoma differentiation as-
sociated gene 5 (MDA5), a molecule showing homology
to RIG-I, has also been implicated in the recognition of
viral dsRNA (Andrejeva et al., 2004; Kang et al., 2002). In
addition, these proteins bind poly I:C. The protein LGP2
also shares homology with RIG-I in the helicase domain,
although it lacks a CARD (Rothenfusser et al., 2005;
Yoneyama et al., 2005). It has been suggested that
LGP2 acts as a negative regulator of RIG-I/MDA-5 sig-
naling. Analyses of RIG-I/ cells revealed that RIG-I is
essential for the induction of type I IFN responses after
RNA virus infection (Kato et al., 2005).
Recently, expression cloning studies have identified
IPS-1, an adaptor protein composed of an N-terminal
CARD domain resembling that of MDA-5 or RIG-I (Kawai
et al., 2005). This protein was also independently isolated
and functionally characterized by several groups and has
also been designated, MAVS, VISA, or CARDIF (Meylan
et al., 2005; Seth et al., 2005; Xu et al., 2005). When ex-Cpressed in human cells, this protein has the ability to
induce the activation of the type I IFN promoter as well
as NF-kB. IPS-1 associates with RIG-I or MDA5 via their
CARD domains, suggesting that IPS-1 acts as an adaptor
for RIG-I and MDA-5. Consistently, RNAi-mediated
knockdown of IPS-1 resulted in inhibition of dsRNA- or
RNA-virus-induced type I IFN responses. These findings
indicate that IPS-1/MAVS/VISA/CARDIF plays an essen-
tial role in RIG-I/MDA5 signaling. Interestingly, this protein
is present in the outer mitochondrial membrane, suggest-
ing that mitochondria might be important for IFN re-
sponses in addition to their roles in metabolism and cell
death (Seth et al., 2005). Downstream of RIG-I-IPS-1,
TBK1 and IKK-i are activated to phosphorylate IRF-3
and IRF-7, indicating that the signaling pathways triggered
by TLR stimulation and RIG-I converge at the level of
TBK1/IKK-i.
FADD and RIP1 have been reported to be required
for type I IFN production in response to dsRNA, and
FADD/ or RIP1/ MEFs have been shown to be highly
susceptible to VSV infection (Balachandran et al., 2004).ell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc. 793
IPS-1 interacts with FADD and RIP1 via the non-CARD
region to facilitate NF-kB activation. Taken together, this
evidence suggests that IPS-1 is an adaptor linking RIG-I
and MDA5 to downstream signaling mediators including
FADD, RIP1, TBK1 and IKK-i. However, virus-induced
type I IFN responses are not impaired in FADD/ cells
(Yoneyama et al., 2005). Further analyses are therefore
required to clarify the roles of FADD and RIP1 in the IFN
response to viral infection.
How do RIG-I and TLR3 differ in their recognition of viral
components? Given that RIG-I and TLR3 are localized in
the cytoplasm and on endosomal membrane, respec-
tively, it is hypothesized that the viral entry route may
determine the contribution of each. However, some evi-
dence suggests that the route of infection is not so critical.
For example, Sendai virus and VSV infect cells via different
routes, namely cell fusion and endosomal entry, respec-
tively, yet both induce the production of type I IFNs in
cDCs via RIG-I, but not via TLR3,. These suggest that
RNA viruses actively replicating in the cytoplasm are rec-
ognized by RIG-I, but not TLR3, irrespective of their route
of entry. On the other hand, TLR3 has been suggested to
be responsible for the recognition of dsRNA contained in
the apoptotic bodies of virus-infected cells taken up by
DCs.
Interestingly, pDCs from RIG-I/ and wild-type mice
produce a comparable amount of IFN-a in response to
NDV stimulation, indicating that pDCs mainly use mecha-
nisms for the induction of IFNs that do not involve RIG-I
(Kato et al., 2005). In pDCs, the TLR system appears to
play more important role in the induction of type I IFNs.
These observations suggest that pDCs have developed
specialized mechanisms for the detection of viruses.
Given that UV-inactivated virus particles are still capable
of inducing type I IFNs via TLRs, it is unlikely that the rep-
lication of viruses in pDCs is needed for their recognition
(Lund et al., 2003). Moreover, it is well known that pDCs
are difficult to infect with viruses. Therefore, viral recogni-
tion in pDCs may mainly depend on endocytosis of viral
particles rather than direct infection. However, further
studies are needed to uncover the mechanisms of the
cell-type-specific viral recognition.
As described in Viral DNA Is Recognized by TLR9, infec-
tion with DNA viruses such as HSV1 induces type I IFN
production in both TLR9-dependent and -independent
manners. Similar to dsRNA, viral DNA is also recognized
in the cytoplasm independently of the TLRs. Induction of
type I IFNs by cytoplasmic DNA is dependent on TBK1/
IKK-i and IPS-1 and is independent on RIG-I, implying
that infected viral DNA is recognized by an unknown
PRR that signals via IPS-1 and TBK1/IKK-i (Ishii et al.,
2005).
Escape of Pathogens from Innate
Immune Recognition
Viruses employ multiple strategies to evade the host
immune system. A number of viral proteins inhibit host
immune responses, prevent viral antigen presentation,794 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.and abrogate induction of cell death. Given their roles in
detecting viruses, it is not surprising that molecules
involved in TLR signaling, particularly TIR-domain-
containing adaptors, are the targets of viral immune
disturbance. For example, vaccinia virus produces the
TIR-domain-containing proteins A46R and A52R, which
target host MyD88 and TRIF, and suppresses TLR- or
IL-1R-induced NF-kB activation (Bowie et al., 2000; Stack
et al., 2005). Vaccinia virus also encodes N1L, a protein
that antagonizes TLR signaling at the level of IKKs and
TBK1 (DiPerna et al., 2004). Another strategy by which vi-
ruses evade antiviral immunity is the processing of host
signaling molecules. Hepatitis C virus (HCV) encodes
NS3/4A protease, which blocks IRF-3 activation by cleav-
ing TRIF and thereby subverting poly I:C-mediated activa-
tion of IFN responses (Li et al., 2005).
Since the RIG-I/MDA-5 system is critical for host
defense against RNA viruses, wemight expect that its sig-
naling cascades are also targeted by viruses to evade
immune responses. In fact, various proteins encoded by
RNA viruses have been shown to antagonize the RIG-I/
MDA5 pathway to inhibit type I IFN responses. The V pro-
teins of paramyxoviruses associate with MDA-5, but not
with RIG-I, and inhibit dsRNA-induced activation of the
IFN-b promoter (Andrejeva et al., 2004). HCV NS3/4A pro-
tease also targets IPS-1/MAVS/VISA/CARDIF (Meylan
et al., 2005). Moreover, various RNA viruses and their
proteins suppress IRF activation as well as type I IFN pro-
duction, although their precisemechanisms have yet to be
understood.
DNA viruses have also developed various strategies to
inhibit host immune surveillance. First, the genomic DNA
of certain adenoviruses contains an unusually low fre-
quency of the immunostimulatory CpG-DNA, thereby
avoiding immune surveillance by TLR9. In addition, path-
ways activating IRFs are suppressed by DNA viruses.
The ICP0 and ICP34.5 proteins from HSV1 inhibit IRF-3
activation, and a ubiquitin E3 ligase RTA encoded by the
Kaposi’s sarcoma-associated herpesvirus (KSHV) pro-
motes IRF-7 ubiquitination and proteasome-mediated
degradation (Lin et al., 2004; Yu et al., 2005). These indi-
cate that both RNA and DNA viruses can hamper host
type I IFN production and suggest that controlling the
IFN response is essential for the survival of a broad range
of viruses.
Bacteria and fungi are also able to exploit the TLR sys-
tem to evade host immune responses. Certain pathogens
have modified forms of the normal TLR ligands, such as
the LPSs from H. pylori, P. gingivalis, and L. pneumophila
and flagellin of H. pylori and C. jejuni (Andersen-Nissen
et al., 2005). Some pathogens modify the TLR signaling
pathways for their benefits. M. tuberculosis avoids being
killed by macrophages by inhibiting IFN-g-mediated sig-
naling. Prolonged signaling with a 19 kDa lipoprotein
from Mycobacterium, which stimulates TLR2, inhibits
IFN-g production and major histocompatibility complex
(MHC) class II antigen-processing activity (Fortune et al.,
2004; Pai et al., 2003). These findings suggest that, at least
Figure 5. The Toll and Imd Pathways in Drosophila
Infection by fungi and Gram-positive bacteria activates the Toll signaling pathway. GNBP1 and PGRP-SA recognize Gram-positive bacteria and trig-
ger activation of protease cascades, leading to the cleavage of Spaetzle. Spaetzle binds Toll, initiates signaling pathways by recruiting dMyD88 and
Pelle, and induces nuclear translocation of the Rel-type transcription factors Dorsal and DIF. Gram-negative bacterial infection is sensed by PGRP-
LC, and the Imd pathway is activated. Downstream of the Imd gene, dTAK1 and dFADD function as a IKK kinase and a Dredd activator, respectively.
Relish is phosphorylated by the IKK and cleaved by Dredd, leading to the induction of antimicrobial-peptide genes.in part, persistent TLR2 signaling enablesMycobacterium
to evade T cell responses and persist as a long-term infec-
tion. Similarly, pathogenic Yersinia species release V anti-
gen (LcrV), a virulence factor that stimulates the produc-
tion of IL-10 via TLR2 and suppresses production of TNF
and IFN-g. As a consequence, TLR2/ mice are actually
less susceptible to oral infection with Yersinia enterocoli-
tica (Sing et al., 2002).
Evolutionary Aspects of Innate Immunity
Advances in a number of genome projects have revealed
that the TLR genes are conserved among many verte-
brates, including chicken, Xenopus, zebrafish, and the
Japanese pufferfish Takifugu rubripes (Roach et al.,
2005). Mammalian TLRs are subdivided into six families
based on their sequence similarities. A bioinformatics
analysis revealed that all of these families are conserved
among vertebrates from Takifugu and Xenopus to mam-
mals. Indeed, mammalian TLR ligands, such as dsRNA,
CpG-DNA, and flagellin, are immunostimulatory in the
fish. This conservation suggests that there is littlemutation
or variation among the PAMPs recognized by TLRs and
that selective pressure to recognize these PAMPs tropicCto a broad range of vertebrates maintains the repertoire
of TLRs that detect them.
Although it was the initial discovery and characterization
ofDrosophila Toll that led to the identification of vertebrate
TLRs, subsequent studies have revealed large differences
in the pathogen recognition mechanisms between verte-
brates and flies (Hoffmann, 2003). The Drosophila Toll
pathway is activated in response to infections by fungi
and Gram-positive bacteria. It is well known thatDrosoph-
ila Toll activates signaling cascades closely resembling
the mammalian TLR signaling pathway. However, unlike
the mammalian system, Drosophila Toll does not directly
recognize fungal and bacterial components but rather in-
teracts with endogenous ligands generated by a protease
cascade (Figure 5). Invading Gram-positive bacteria are
recognized by PG-recognition proteins (PGRP) followed
by the activation of the Toll ligand Spaetzle via the prote-
ase cascade (Michel et al., 2001). In Drosophila, the Toll
family consists of ninemembers, although other Toll family
members may not be involved in antimicrobial immune
responses. On the other hand, Gram-negative bacterial
infection activates the Imd pathway, but not the Toll
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amember of thePGRP family containing a transmembrane
domain have been identified as a PRR in the Imd pathway
(Gottar et al., 2002). The IMD protein contains a death do-
main that has high homology to that of mammalian RIP
(Hoffmann, 2003). Drosophila homologs of FADD, TAK1,
and IKK-b are also involved in the Imd pathway. Activation
of the Drosophila IKK-b leads to phosphorylation of a
NF-kB-like protein, Relish, resulting in its cleavage and
subsequent nuclear translocation. In turn, Relish induces
the expression of genes encoding antimicrobial peptides
against Gram-negative bacteria. Drosophila antiviral im-
mune responses are less understood, although it is known
that there are JAK-STAT-dependent and -independent
pathways modulating transcriptional responses against
Drosophila C virus infection (Dostert et al., 2005).
TLRs exist in primitive metazoans as well. A single Toll
homolog has been identified in C. elegans and termed
Tol-1 (Pujol et al., 2001). Tol-1 expression in adults is
restricted to the nervous system and is implicated in
embryonic development and pathogen recognition.
Tol-1 mutants are susceptible to bacterial infection due
to impaired pathogen avoidance. These suggest that
Tol-1 contributes to the recognition of a specific bacterial
component (or components) and elicits in a change in
C. elegans behavior. Furthermore, it has been shown
that a TIR-containing adaptor, TIR-1, is critical for resis-
tance to pathogens via activation of p38 MAP kinase
(Couillault et al., 2004). However, the activity of TIR-1 is
independent of the single Toll homolog, and the function
of its mammalian homolog, SARM1, is not yet understood.
Plants infected with pathogens activate host defense
responses, including elimination of infected cells, called
the hypersensitive response, and antibiotic production
at the site of infection. Although plants do not possess
TLRs, a family of multiple NOD-LRR proteins, called resis-
tance (R) proteins, play a critical role in the host defense
(Belkhadir et al., 2004). In Arabidopsis, effector domains
of the R proteins contain TIR, leucine-zipper-like, or
coiled-coil domains. Arabidopsis has more than 149
genes encoding R proteins in its genome. R protein-medi-
ated signaling induces the hypersensitive response, which
is a form of programmed cell death, to prevent the spread
of infection. Whereas mammalian NOD-LRR proteins rec-
ognize PG components directly, plant R proteins are
shown to indirectly detect bacterial proteins (Belkhadir
et al., 2004). In addition, the plant genome encodes
another type of PRRs that are composed of LRRs, a trans-
membrane domain, and a serine/threonine kinase do-
main. The flagellin-sensitive receptor (FLS2) of Arabidop-
sis thaliana is an extensively studied receptor-like kinase
(Gomez-Gomez and Boller, 2000). As the name indicates,
FLS2 detects flagellinmonomers and is functionally equiv-
alent to mammalian TLR5. However, the LRR domain of
FLS2 is different in amino acid sequence from that of
TLR5 and recognizes distinct regions of flagellin mono-
mers. These results may indicate that the LRR structure
has been independently selected in plants and mammals
for the detection of flagellin. Downstream of FLS2, a MAP796 Cell 124, 783–801, February 24, 2006 ª2006 Elsevier Inc.kinase cascade and WRKY transcription factors are acti-
vated to induce effector proteins.
Taken together, immune recognition is mediated by
PRRs that are composed of a related set of domains
throughout different species. However, the details of path-
ogen recognition and signaling mechanisms differ signifi-
cantly among species, especially between vertebrate and
invertebrate plants or animals. This indicates that ancient
innate immunity has branched off into a variety of unique
and specialized systems in each species during evolution.
Future Perspectives
There has been considerable recent expansion in our
knowledge of host innate immune responses against
pathogen infection. These responses involve some very
sophisticated mechanisms for detecting various patho-
gens using a limited number of PRRs and induction of
adaptive responses. In particular, dissection of the func-
tions of the various TLRs and their signaling pathways
has revealed thatmammalian innate immune cells activate
distinct signaling pathways depending on the pathogen
involved in the infection and mount adaptive cytokine re-
sponses for each.
However, there are other systems for recognizing path-
ogens that do not involve the TLRs: In particular, the de-
tection of pathogens via cytoplasmic PRRs plays a critical
role in mounting immune responses. Amore complete de-
scription of the cytoplasmic PRRs and their functions
awaits future study. In addition, the relationships among
the TLR system and cytoplasmic PRRs, as well as the de-
tails of the mechanisms of TLR-independent activation of
adaptive immunity, are quite intriguing issues that remain
to be clarified. Accumulating evidence suggests that
these different systems function in a cell-type-specific
manner. Furthermore, cooperation between immune cells
is critical for the rapid elimination of pathogens in vivo.
Natural killer (NK) cells are known to detect microbial in-
fection via a non-TLR receptor system, and the interaction
between DCs and NK cells is prerequisite for mounting ef-
ficient innate immune responses. In summary, the mech-
anisms of cytoplasmic pathogen recognition and the role
of these PRRs in activating immune responses in vivo
are important future topics to be investigated.
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